RANZCP homepage
Application to the PBAC July 2024 Agenda for the Subsidy of Lecanemab and Esketamine
Submission
Last updated: Jun 2024
Published in Australia
Reference: 07AUS
RANZCP Submission to the Pharmaceutical Benefits Advisory Committee (PBAC) regarding the Application to the PBAC July 2024 Agenda for the Subsidy of Lecanemab and Esketamine
